-
Je něco špatně v tomto záznamu ?
Evaluation of the effects of N-acetylcysteine on serum glucose, lipid profile, and body weight in rats with fructose-induced metabolic syndrome
Auss Z. Yahya, Ghada A. Taqa, Muhammad A. Alkataan
Jazyk angličtina Země Česko
Digitální knihovna NLK
Zdroj
NLK
ROAD: Directory of Open Access Scholarly Resources
od 2011
- MeSH
- acetylcystein * aplikace a dávkování farmakologie MeSH
- fruktosa aplikace a dávkování škodlivé účinky MeSH
- krevní glukóza účinky léků MeSH
- krysa rodu rattus MeSH
- metabolický syndrom * chemicky indukované farmakoterapie krev MeSH
- modely nemocí na zvířatech MeSH
- tělesná hmotnost účinky léků MeSH
- výsledek terapie MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
Background: Overconsumption of fructose may cause metabolic syndrome (MetS). MetS pathogenesis is caused by oxidative stress, cellular malfunction, and systemic inflammation caused by hereditary and environmental factors. N-acetylcysteine (NAC) has become associated with the phrase "antioxidant." Most researchers use and test NAC with the goal of preventing or reducing oxidative stress.Aim: To determine the positive effects of NAC on blood glucose, lipid profile, and body weight in fructose-induced metabolic syndrome in albino rats.Materials and Methods: Forty male albino rats, 10-12 weeks old, were haphazardly divided into five groups of identical size. Group I (negative control) received tap water for 12 weeks. Group II (positive control) received a 60% w/w fructose solution (60% FS) instead of tap water for 12 weeks. Group III (NAC) received tap water and an intra-peritoneal (IP) injection of NAC (150 mg/kg/day) for 12 weeks. Group IV (protection) co-administered 60% FS orally and NAC IP injection (150 mg/kg/day) for 12 weeks. Group V (treatment) received 60% FS for 8 weeks followed by 4 weeks of drinking tap water with NAC IP injection (150 mg/kg/day). Blood samples were taken at weeks 0, 8, and 12 and were tested for serum glucose and lipid profile. All animals of each group were weighted at weeks 0, 8 and 12 of the study.Results: Concerning serum glucose, group II showed increased glycaemia at week 8 and further elevation during week 12. Group III displayed normal glycaemia at weeks 8 and 12. In group IV, glycaemia showed elevation at week 8 followed by almost complete restoration at week 12. In group V, there was an increased glycaemia at week 8 followed by a partial restoration at week 12. Regarding lipid profile parameters, group II demonstrated a deterioration during week 8 and more worsening during week 12. There were no significant changes in group III's parameters during weeks 8 and 12. Group IV displayed a worsening in lipid profile during week 8 followed by a nearly complete improvement during week 12. During week 8, group V deteriorated, followed by a partial recovery during week 12. Concerning body weight, group II showed a weight gain at week 8 and further elevation during week 12. Group III displayed normal glycaemia at weeks 8 and 12. In group IV, glycaemia showed elevation at week 8 followed by almost complete restoration at week 12. In group V, there was an increased glycaemia at week 8 followed by a partial restoration at week 12. At week 8, there was a significant elevation in body weights in groups II and V compared to group I. Moreover, a significant reduction in body weight was recorded in group IV compared to group II during week 8. At week 12, a significant elevation in body weight was noticed in groups II and V compared to group I. Moreover, there was a significant reduction in body weight in group III compared to group I. On the other hand, there was a significant fall in body weight in groups IV and V compared to group II during week 12.Conclusion: MetS was caused by a high-fructose diet, which has been shown to have a negative impact on serum glucose, lipid profiles, and body weight. Moreover, NAC has been shown to enhance these parameters in a time-dependent manner.
Department of Biochemistry College of Medicine University of Ninevah Mosul Iraq
Department of Dental Basic Sciences College of Dentistry University of Mosul Mosul Iraq
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23013697
- 003
- CZ-PrNML
- 005
- 20231110100344.0
- 007
- ta
- 008
- 230913s2023 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.31482/mmsl.2022.039 $2 doi
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Yahya, Auss Z. $u Ministry of Health, Ninevah Heath Directorate, Mosul, Iraq
- 245 10
- $a Evaluation of the effects of N-acetylcysteine on serum glucose, lipid profile, and body weight in rats with fructose-induced metabolic syndrome / $c Auss Z. Yahya, Ghada A. Taqa, Muhammad A. Alkataan
- 504 __
- $a Literatura
- 520 9_
- $a Background: Overconsumption of fructose may cause metabolic syndrome (MetS). MetS pathogenesis is caused by oxidative stress, cellular malfunction, and systemic inflammation caused by hereditary and environmental factors. N-acetylcysteine (NAC) has become associated with the phrase "antioxidant." Most researchers use and test NAC with the goal of preventing or reducing oxidative stress.Aim: To determine the positive effects of NAC on blood glucose, lipid profile, and body weight in fructose-induced metabolic syndrome in albino rats.Materials and Methods: Forty male albino rats, 10-12 weeks old, were haphazardly divided into five groups of identical size. Group I (negative control) received tap water for 12 weeks. Group II (positive control) received a 60% w/w fructose solution (60% FS) instead of tap water for 12 weeks. Group III (NAC) received tap water and an intra-peritoneal (IP) injection of NAC (150 mg/kg/day) for 12 weeks. Group IV (protection) co-administered 60% FS orally and NAC IP injection (150 mg/kg/day) for 12 weeks. Group V (treatment) received 60% FS for 8 weeks followed by 4 weeks of drinking tap water with NAC IP injection (150 mg/kg/day). Blood samples were taken at weeks 0, 8, and 12 and were tested for serum glucose and lipid profile. All animals of each group were weighted at weeks 0, 8 and 12 of the study.Results: Concerning serum glucose, group II showed increased glycaemia at week 8 and further elevation during week 12. Group III displayed normal glycaemia at weeks 8 and 12. In group IV, glycaemia showed elevation at week 8 followed by almost complete restoration at week 12. In group V, there was an increased glycaemia at week 8 followed by a partial restoration at week 12. Regarding lipid profile parameters, group II demonstrated a deterioration during week 8 and more worsening during week 12. There were no significant changes in group III's parameters during weeks 8 and 12. Group IV displayed a worsening in lipid profile during week 8 followed by a nearly complete improvement during week 12. During week 8, group V deteriorated, followed by a partial recovery during week 12. Concerning body weight, group II showed a weight gain at week 8 and further elevation during week 12. Group III displayed normal glycaemia at weeks 8 and 12. In group IV, glycaemia showed elevation at week 8 followed by almost complete restoration at week 12. In group V, there was an increased glycaemia at week 8 followed by a partial restoration at week 12. At week 8, there was a significant elevation in body weights in groups II and V compared to group I. Moreover, a significant reduction in body weight was recorded in group IV compared to group II during week 8. At week 12, a significant elevation in body weight was noticed in groups II and V compared to group I. Moreover, there was a significant reduction in body weight in group III compared to group I. On the other hand, there was a significant fall in body weight in groups IV and V compared to group II during week 12.Conclusion: MetS was caused by a high-fructose diet, which has been shown to have a negative impact on serum glucose, lipid profiles, and body weight. Moreover, NAC has been shown to enhance these parameters in a time-dependent manner.
- 650 17
- $a acetylcystein $x aplikace a dávkování $x farmakologie $7 D000111 $2 czmesh
- 650 _7
- $a krevní glukóza $x účinky léků $7 D001786 $2 czmesh
- 650 _7
- $a tělesná hmotnost $x účinky léků $7 D001835 $2 czmesh
- 650 17
- $a metabolický syndrom $x chemicky indukované $x farmakoterapie $x krev $7 D024821 $2 czmesh
- 650 _7
- $a fruktosa $x aplikace a dávkování $x škodlivé účinky $7 D005632 $2 czmesh
- 650 _7
- $a modely nemocí na zvířatech $7 D004195 $2 czmesh
- 650 _7
- $a krysa rodu Rattus $7 D051381 $2 czmesh
- 650 _7
- $a výsledek terapie $7 D016896 $2 czmesh
- 650 _7
- $a mužské pohlaví $7 D008297 $2 czmesh
- 700 1_
- $a Taqa, Ghada A. $u Department of Dental Basic Sciences, College of Dentistry, University of Mosul, Mosul, Iraq
- 700 1_
- $a Alkataan, Muhammad A. $u Department of Biochemistry, College of Medicine, University of Ninevah, Mosul, Iraq
- 773 0_
- $t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 92, č. 3 (2023), s. 194-207 $w MED00011116
- 856 41
- $u https://mmsl.cz/artkey/mms-202303-0001_evaluation-of-the-effects-of-n-acetylcysteine-on-serum-glucose-lipid-profile-and-body-weight-in-rats-with-fru.php $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 3 $c 1073 $y p $z 0
- 990 __
- $a 20230905 $b ABA008
- 991 __
- $a 20231110100337 $b ABA008
- 999 __
- $a ok $b bmc $g 1983179 $s 1200007
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2023 $b 92 $c 3 $d 194-207 $e 20230901 $i 0372-7025 $m Vojenské zdravotnické listy $x MED00011116
- LZP __
- $c NLK189 $d 20231102 $b NLK111 $a Actavia-MED00011116-20230905